Skip to content

Comparison of remazolam and dexmedetomidine in endoscopic retrograde cholangiopancreatography

Comparison of remazolam and dexmedetomidine in endoscopic retrograde cholangiopancreatography

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057936
Enrollment
Unknown
Registered
2022-03-23
Start date
2022-03-23
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERCP

Interventions

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Perform ERCP at a selected time; 2. ASA grade I-III, age >= 18 years; 3. 18 kg/m2 <= BMI < 30 kg/m2; 4. No history of other serious diseases, alcohol abuse and recent respiratory tract infection.

Exclusion criteria

Exclusion criteria: 1. Difficult airway; 2. The expected operation time is more than 3 h; 3. History of sedative and analgesic drug abuse; 4. Patients who cannot communicate before surgery due to delirium, dementia, central peripheral nervous system diseases, or language disorders; 5. Allergies to study drugs; 6. Previous history of adverse sedation events.

Design outcomes

Primary

MeasureTime frame
Respiratory events;

Secondary

MeasureTime frame
Mean arterial pressure;Intraoperative adverse events;Postoperative complications;Heart rate;

Countries

China

Contacts

Public ContactLuyao Yang

Liaocheng People's Hospital

byfyyly@163.com+86 17661850665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026